Sangeeta N. Bhatia - 29 Jul 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
29 Jul 2022
Net transactions value
-$173,116
Form type
4
Filing time
02 Aug 2022, 16:16:12 UTC
Previous filing
04 May 2022
Next filing
10 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $27,388 -99 -1.7% $276.65 5,804 29 Jul 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $55,590 -200 -3.4% $277.95 5,604 29 Jul 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $44,685 -160 -2.9% $279.28 5,444 29 Jul 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $27,742 -99 -1.8% $280.22 5,345 29 Jul 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $16,300 -58 -1.1% $281.03 5,287 29 Jul 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale $1,412 -5 -0.09% $282.34 5,282 29 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
F2 Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $276.65 (range $276.21 to $276.83).
F4 Open market sales reported on this line occurred at a weighted average price of $277.95 (range $277.63 to $278.35).
F5 Open market sales reported on this line occurred at a weighted average price of $279.28 (range $278.86 to $279.83).
F6 Open market sales reported on this line occurred at a weighted average price of $280.22 (range $279.88 to $280.78).
F7 Open market sales reported on this line occurred at a weighted average price of $281.03 (range $280.93 to $281.08).